Exact Mass: 490.133117

Exact Mass Matches: 490.133117

Found 27 metabolites which its exact mass value is equals to given mass value 490.133117, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tesevatinib

7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine

C24H25Cl2FN4O2 (490.1338501999999)


   

Bisindigotin

Bisindigotin

C32H18N4O2 (490.14296879999995)


   

retipolide A 5-O-methyl ether

retipolide A 5-O-methyl ether

C27H22O9 (490.1263762)


   

bergenin-8-O-alpha-L-rhamnoside

bergenin-8-O-alpha-L-rhamnoside

C20H26O14 (490.1322496)


   

parvifloral F

parvifloral F

C27H22O9 (490.1263762)


   

Precercosporin

Precercosporin

C27H22O9 (490.1263762)


   

(1R,4aS,9aR,E)-3-(3,5-dihydroxystyryl)-6,8,9a-trihydroxy-1-(3,4,5-trihydroxyphenyl)-1,4,4a,9a-tetrahydrofluoren-9-one|syagrusin A

(1R,4aS,9aR,E)-3-(3,5-dihydroxystyryl)-6,8,9a-trihydroxy-1-(3,4,5-trihydroxyphenyl)-1,4,4a,9a-tetrahydrofluoren-9-one|syagrusin A

C27H22O9 (490.1263762)


   

Cys Cys Glu His

(4S)-4-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)


   

Cys Cys His Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]pentanedioic acid

C17H26N6O7S2 (490.1304326)


   

Cys Glu Cys His

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1R)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)


   

Cys Glu His Cys

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)


   

Cys His Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]pentanedioic acid

C17H26N6O7S2 (490.1304326)


   

Cys His Glu Cys

(4S)-4-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)


   

Glu Cys Cys His

(4S)-4-amino-4-{[(1R)-1-{[(1R)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)


   

Glu Cys His Cys

(4S)-4-amino-4-{[(1R)-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)


   

Glu His Cys Cys

(4S)-4-amino-4-{[(1S)-1-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)


   

His Cys Cys Glu

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]pentanedioic acid

C17H26N6O7S2 (490.1304326)


   

His Cys Glu Cys

(4S)-4-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)


   

His Glu Cys Cys

(4S)-4-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-{[(1R)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C17H26N6O7S2 (490.1304326)


   

Clindamycin B 2-Phosphate

Clindamycin B 2-Phosphate

C17H32ClN2O8PS (490.13054320000003)


   

AM966

AM966

C27H23ClN2O5 (490.1295418)


   

XL-647

Tesevatinib

C24H25Cl2FN4O2 (490.1338501999999)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents

   

N-(1-Cyanocyclopropyl)-3-({[(2S)-5-oxopyrrolidin-2-YL]methyl}sulfonyl)-N~2~-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-L-alaninamide

N-(1-Cyanocyclopropyl)-3-({[(2S)-5-oxopyrrolidin-2-YL]methyl}sulfonyl)-N~2~-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-L-alaninamide

C20H22F4N4O4S (490.12978200000003)


   

1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]piperidine-4-carboxamide

1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]piperidine-4-carboxamide

C22H26N4O5S2 (490.1344546)


   

1-(4-Bromophenyl)-2-[3-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octan-1-yl]ethanone

1-(4-Bromophenyl)-2-[3-[hydroxy(diphenyl)methyl]-1-azoniabicyclo[2.2.2]octan-1-yl]ethanone

C28H29BrNO2+ (490.1381534)


   

20-Oxopregn-5-ene-3beta,21-diyl disulfate

20-Oxopregn-5-ene-3beta,21-diyl disulfate

C21H30O9S2-2 (490.133117)


   

21-hydroxypregnenolone disulfate(2-)

21-hydroxypregnenolone disulfate(2-)

C21H30O9S2 (490.133117)


A 21-hydroxypregnenolone disulfate anion obtained by deprotonation of both sulfate groups of 21-hydroxypregnenolone disulfate.